Announced Fri, 10 Jul · 19:57 IST
Quarterly demat certificate filed with BSE for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Ganga Pharmaceuticals has submitted the quarterly certificate under SEBI Regulation 74(5) for April to June 2026. The certificate, issued by KFin Technologies as RTA, confirms share dematerialisation requests were processed within 15 days and cancelled share certificates were mutilated. Details were also furnished to NSDL and CDSL. This is a routine quarterly compliance filing.
Likely market impact
Routine regulatory filing; no material impact on the company or its shareholders.